Washington University School of Medicine: Study Identifies Benefits, Risks Linked to Popular Weight-Loss Drugs
January 21, 2025
January 21, 2025
ST. LOUIS, Missouri, Jan. 21 (TNSjou) -- The Washington University School of Medicine issued the following news release:
* * *
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems
* * *
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently u . . .
* * *
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems
* * *
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently u . . .